BIND THERAPEUTICS INC Inactive Instrument
Company BIND Therapeutics Inc Nasdaq
Equities
US05548N1072
Biotechnology & Medical Research
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 06-10-31 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
| Corporate Officer/Principal | - | 16-07-23 | |
James L. Wright
PRN | Corporate Officer/Principal | 76 | 06-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 16-07-23 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 20,886,802 | 17,860,424 ( 85.51 %) | 0 | 85.51 % |
Company contact information
DNIB Unwind, Inc.
333 South Grand Avenue Suite 4100
90071, Los Angeles
+617-491-3400
http://bindtherapeutics.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -3.39% | 102B | |
| +2.61% | 96.09B | |
| -1.02% | 22.05B | |
| -18.14% | 20.81B | |
| -6.87% | 19.06B | |
| -40.70% | 16.05B | |
| -26.89% | 14.01B | |
| +1.12% | 13.38B | |
| +22.25% | 11.01B |
